Lunsumio for Follicular Lymphoma User Reviews

Mik...
Taken for 1 to 6 months
March 12, 2024

"I've had 4 treatments, 1mg, 2mg, and 2 - 60mg. I've been extremely tired after the two 60mg treatments. Unable to stand without assistance for a few days after treatment. Could not read or comprehend my daily readings. After 12 days from my last treatment, I am just now beginning to be able to take walks and short hikes. I intend to take two more 30mg treatments and then stop so I can enjoy a two-week trip to Hawaii. Upon returning in mid-June, I will meet with my oncologist and the City of Hope doctors for further evaluation and treatment."

8 / 10

Was this helpful?Yes No

0 Report

Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.

Learn more about Follicular Lymphoma

Care guides

More about Lunsumio (mosunetuzumab)

Patient resources

Lunsumio drug information

Professional resources

Related treatment guides

Follicular Lymphoma

Drug Status

Availability Prescription only Rx

Pregnancy & Lactation Risk data available

CSA Schedule* Not a controlled drug N/A

Approval History Drug history at FDA

Drug Class

Bispecific T-cell engagers (BiTE)

Images

Pill medicine is Lunsumio 30 mg/30 mL (1 mg/mL) injection — Lunsumio 30 mg/30 mL (1 mg/mL) injection

Lunsumio for Follicular Lymphoma User Reviews

See also:

Rituxan

Monjuvi

Truxima

Breyanzi

Kymriah

Polivy

Yescarta

Zynlonta

Xpovio

Tazverik

Are you taking this medicine?